| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
46,966 |
35,780 |
$12.04M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
56,769 |
46,657 |
$10.43M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
29,251 |
22,331 |
$3.67M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,622 |
6,054 |
$3.57M |
| 97010 |
|
41,716 |
10,248 |
$2.58M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
30,131 |
19,587 |
$2.05M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
74,207 |
17,340 |
$1.84M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,970 |
8,166 |
$1.73M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,819 |
2,241 |
$1.57M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,513 |
2,244 |
$1.20M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
24,781 |
17,387 |
$1.02M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17,309 |
14,420 |
$999K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,856 |
7,785 |
$995K |
| S9480 |
Intensive outpatient psychiatric services, per diem |
9,140 |
1,595 |
$945K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,848 |
6,052 |
$904K |
| 59025 |
Fetal non-stress test |
8,783 |
2,328 |
$892K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,070 |
5,551 |
$811K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
21,783 |
15,522 |
$792K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,645 |
1,398 |
$722K |
| 71046 |
Radiologic examination, chest; 2 views |
12,527 |
10,536 |
$659K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,615 |
2,291 |
$619K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,655 |
3,726 |
$598K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,113 |
1,562 |
$582K |
| 71045 |
Radiologic examination, chest; single view |
12,358 |
9,919 |
$568K |
| 93975 |
|
2,781 |
2,362 |
$532K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,216 |
10,677 |
$498K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,295 |
4,105 |
$470K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
651 |
597 |
$466K |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,220 |
7,345 |
$456K |
| 97161 |
|
7,211 |
6,440 |
$407K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
33,608 |
12,582 |
$407K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,323 |
2,665 |
$372K |
| 90832 |
Psychotherapy, 30 minutes with patient |
11,235 |
6,359 |
$354K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12,253 |
11,047 |
$333K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12,250 |
11,045 |
$332K |
| 97597 |
|
4,033 |
1,935 |
$319K |
| 90791 |
Psychiatric diagnostic evaluation |
3,121 |
2,702 |
$300K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,839 |
3,262 |
$299K |
| 86900 |
|
8,555 |
6,114 |
$296K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,146 |
1,809 |
$290K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
468 |
427 |
$263K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14,026 |
11,808 |
$257K |
| 84443 |
Thyroid stimulating hormone (TSH) |
26,419 |
22,890 |
$252K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
899 |
791 |
$244K |
| 97035 |
|
9,605 |
2,993 |
$242K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,296 |
1,872 |
$231K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,780 |
1,532 |
$228K |
| 76801 |
|
2,559 |
1,844 |
$220K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,454 |
2,167 |
$219K |
| 80053 |
Comprehensive metabolic panel |
71,601 |
55,715 |
$212K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
1,749 |
351 |
$211K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
11,076 |
9,710 |
$211K |
| 94060 |
|
1,464 |
1,339 |
$207K |
| 80061 |
Lipid panel |
23,396 |
20,763 |
$201K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
304 |
271 |
$201K |
| 76830 |
Ultrasound, transvaginal |
1,933 |
1,722 |
$188K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,189 |
1,038 |
$182K |
| 90834 |
Psychotherapy, 45 minutes with patient |
3,961 |
2,152 |
$171K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,442 |
4,566 |
$170K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
58,478 |
14,122 |
$169K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
906 |
805 |
$163K |
| 76641 |
|
1,955 |
1,782 |
$162K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
102,258 |
75,857 |
$161K |
| 91065 |
|
1,442 |
854 |
$151K |
| 93971 |
|
2,528 |
2,107 |
$147K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,470 |
2,164 |
$129K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
4,597 |
4,310 |
$125K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
830 |
456 |
$121K |
| 62323 |
|
281 |
255 |
$121K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
819 |
390 |
$117K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
19,757 |
17,416 |
$115K |
| 76775 |
|
2,467 |
2,092 |
$106K |
| 36415 |
Collection of venous blood by venipuncture |
142,807 |
100,978 |
$101K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,184 |
973 |
$99K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,339 |
9,086 |
$98K |
| 88142 |
|
7,582 |
7,090 |
$98K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,765 |
1,495 |
$96K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
8,512 |
7,185 |
$95K |
| 97162 |
|
3,443 |
2,786 |
$94K |
| 71250 |
|
1,747 |
1,492 |
$91K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
837 |
729 |
$84K |
| 82607 |
|
11,269 |
9,623 |
$84K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,689 |
2,066 |
$82K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
15,240 |
12,716 |
$78K |
| 87800 |
|
2,268 |
2,068 |
$77K |
| 93017 |
|
2,271 |
1,944 |
$76K |
| 97602 |
|
1,098 |
580 |
$73K |
| 94010 |
|
1,197 |
1,049 |
$67K |
| 10060 |
|
496 |
411 |
$67K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
4,288 |
4,100 |
$63K |
| 96367 |
|
1,796 |
1,126 |
$62K |
| 88342 |
|
3,609 |
3,116 |
$61K |
| 82728 |
|
9,816 |
8,325 |
$60K |
| 20610 |
|
434 |
345 |
$57K |
| 71271 |
|
645 |
603 |
$57K |
| 97014 |
|
6,434 |
1,742 |
$55K |
| 86780 |
|
5,437 |
4,669 |
$54K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
166 |
93 |
$54K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,081 |
7,803 |
$53K |
| 95811 |
|
80 |
71 |
$52K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
28,848 |
22,555 |
$50K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
40,515 |
28,723 |
$50K |
| 76536 |
|
611 |
550 |
$44K |
| 84439 |
|
7,660 |
6,698 |
$43K |
| 82746 |
|
6,855 |
5,779 |
$41K |
| 86703 |
|
7,220 |
6,176 |
$41K |
| 93970 |
|
359 |
294 |
$40K |
| 83550 |
|
9,778 |
8,302 |
$38K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,598 |
1,921 |
$38K |
| 83970 |
|
1,570 |
1,363 |
$38K |
| 86803 |
|
6,016 |
5,139 |
$37K |
| 95819 |
|
271 |
231 |
$36K |
| 93798 |
|
732 |
107 |
$36K |
| 97012 |
|
881 |
286 |
$35K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,014 |
907 |
$33K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
7,722 |
6,195 |
$32K |
| 86235 |
|
714 |
586 |
$32K |
| 97113 |
|
594 |
160 |
$32K |
| 73221 |
|
181 |
164 |
$32K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
60 |
43 |
$31K |
| 85027 |
|
11,912 |
8,969 |
$30K |
| 83540 |
|
10,028 |
8,517 |
$29K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
100 |
81 |
$27K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28,399 |
20,947 |
$27K |
| 72100 |
|
2,104 |
1,790 |
$25K |
| 73030 |
|
2,680 |
2,235 |
$25K |
| 70496 |
|
164 |
137 |
$25K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,343 |
697 |
$24K |
| 86696 |
|
1,408 |
1,133 |
$23K |
| 73130 |
|
2,302 |
1,983 |
$22K |
| 86480 |
|
505 |
433 |
$22K |
| 86141 |
|
3,914 |
3,326 |
$22K |
| 84425 |
|
1,381 |
1,220 |
$21K |
| 97116 |
|
1,739 |
997 |
$21K |
| 97165 |
|
367 |
315 |
$21K |
| 98968 |
|
449 |
239 |
$21K |
| 84702 |
|
5,534 |
4,005 |
$20K |
| 72110 |
|
313 |
284 |
$19K |
| 72141 |
|
108 |
95 |
$19K |
| 74018 |
|
1,579 |
1,302 |
$18K |
| 87653 |
|
689 |
603 |
$17K |
| 73630 |
|
2,891 |
2,462 |
$17K |
| 0012A |
|
540 |
490 |
$17K |
| 98967 |
|
360 |
229 |
$17K |
| 86038 |
|
2,862 |
2,396 |
$17K |
| 0011A |
|
707 |
547 |
$17K |
| 82105 |
|
1,485 |
1,292 |
$17K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,044 |
979 |
$16K |
| 73502 |
|
1,635 |
1,389 |
$16K |
| 73560 |
|
693 |
589 |
$16K |
| 84153 |
|
1,712 |
1,494 |
$16K |
| 86695 |
|
1,377 |
1,106 |
$15K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
123 |
12 |
$15K |
| 49083 |
|
24 |
12 |
$14K |
| 76642 |
|
274 |
254 |
$14K |
| 77065 |
Tomosynthesis, mammo |
167 |
145 |
$14K |
| 87081 |
|
5,590 |
4,709 |
$14K |
| 87340 |
|
3,659 |
3,097 |
$14K |
| 86706 |
|
2,776 |
2,274 |
$14K |
| 87186 |
|
6,060 |
5,003 |
$13K |
| 87077 |
|
5,913 |
4,868 |
$13K |
| 73610 |
|
2,658 |
2,268 |
$12K |
| 81003 |
|
32,343 |
25,792 |
$12K |
| 64493 |
|
16 |
13 |
$11K |
| 82570 |
|
3,854 |
3,310 |
$11K |
| 82784 |
|
2,505 |
2,075 |
$11K |
| 73700 |
|
170 |
136 |
$11K |
| 86334 |
|
2,102 |
1,646 |
$10K |
| 29515 |
|
89 |
80 |
$10K |
| 82043 |
|
3,144 |
2,771 |
$10K |
| 70491 |
|
58 |
53 |
$10K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
12 |
12 |
$10K |
| 88304 |
|
719 |
602 |
$10K |
| 84403 |
|
585 |
511 |
$10K |
| 73110 |
|
1,648 |
1,410 |
$10K |
| 87147 |
|
5,279 |
4,543 |
$10K |
| 83880 |
|
3,761 |
2,922 |
$10K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
29 |
26 |
$9K |
| 86618 |
|
1,492 |
1,278 |
$9K |
| 93880 |
|
131 |
107 |
$9K |
| 83735 |
|
18,063 |
11,600 |
$9K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
450 |
360 |
$9K |
| 85610 |
|
13,535 |
9,564 |
$9K |
| 83516 |
|
1,044 |
840 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,830 |
2,256 |
$8K |
| 86200 |
|
976 |
845 |
$8K |
| 0001A |
|
268 |
224 |
$8K |
| 0002A |
|
242 |
217 |
$8K |
| 86762 |
|
2,424 |
1,947 |
$8K |
| 85652 |
|
6,873 |
5,754 |
$8K |
| 80076 |
|
7,949 |
6,325 |
$8K |
| 86704 |
|
1,664 |
1,405 |
$7K |
| 81001 |
|
17,670 |
13,228 |
$7K |
| 73564 |
|
2,540 |
2,165 |
$7K |
| 82550 |
|
3,867 |
3,120 |
$7K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
29 |
27 |
$7K |
| Q3014 |
Telehealth originating site facility fee |
841 |
480 |
$6K |
| 87467 |
|
1,365 |
1,178 |
$6K |
| 86140 |
|
2,785 |
2,257 |
$6K |
| 83615 |
|
8,767 |
6,220 |
$6K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
509 |
475 |
$6K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
20 |
12 |
$6K |
| 86787 |
|
2,000 |
1,596 |
$6K |
| 82950 |
|
1,466 |
1,289 |
$6K |
| 99442 |
|
482 |
406 |
$5K |
| 84590 |
|
672 |
591 |
$5K |
| 87088 |
|
2,882 |
2,411 |
$5K |
| 86431 |
|
1,984 |
1,664 |
$5K |
| 84165 |
|
2,007 |
1,625 |
$5K |
| 97018 |
|
76 |
26 |
$5K |
| 87070 |
|
1,574 |
1,287 |
$4K |
| 84480 |
|
444 |
407 |
$4K |
| 87205 |
|
2,538 |
2,049 |
$4K |
| 83690 |
|
25,190 |
19,170 |
$4K |
| 85730 |
|
5,282 |
4,029 |
$4K |
| 64450 |
|
38 |
38 |
$3K |
| 80050 |
General health panel |
232 |
174 |
$3K |
| 83001 |
|
240 |
217 |
$3K |
| 29581 |
|
44 |
12 |
$3K |
| 73080 |
|
524 |
468 |
$3K |
| 86708 |
|
395 |
359 |
$3K |
| 86753 |
|
571 |
482 |
$3K |
| 71101 |
|
502 |
427 |
$3K |
| 82565 |
|
1,961 |
1,644 |
$3K |
| 82040 |
|
1,001 |
887 |
$3K |
| 72070 |
|
115 |
102 |
$3K |
| 96415 |
|
52 |
39 |
$3K |
| 0031A |
|
80 |
76 |
$3K |
| 97535 |
Self-care/home management training, each 15 minutes |
296 |
244 |
$3K |
| 96417 |
|
44 |
24 |
$3K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
17 |
13 |
$2K |
| 84146 |
|
167 |
150 |
$2K |
| 74241 |
|
15 |
14 |
$2K |
| 94664 |
|
71 |
67 |
$2K |
| 73140 |
|
637 |
539 |
$2K |
| 83519 |
|
136 |
81 |
$2K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
2,420 |
1,653 |
$2K |
| 84100 |
|
10,829 |
6,495 |
$2K |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
337 |
304 |
$2K |
| 82247 |
|
1,532 |
1,142 |
$2K |
| 84550 |
|
1,491 |
1,218 |
$2K |
| 74240 |
|
13 |
12 |
$2K |
| 85045 |
|
2,574 |
2,115 |
$2K |
| 84436 |
|
459 |
401 |
$2K |
| 82652 |
|
59 |
54 |
$2K |
| 83525 |
|
190 |
171 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
29 |
26 |
$2K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
27 |
26 |
$2K |
| 84450 |
|
2,705 |
2,316 |
$2K |
| 86225 |
|
210 |
172 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,093 |
970 |
$1K |
| 77066 |
Tomosynthesis, mammo |
16 |
12 |
$1K |
| 85379 |
|
5,073 |
4,218 |
$1K |
| G0378 |
Hospital observation service, per hour |
4,229 |
3,238 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,874 |
1,662 |
$1K |
| 83021 |
|
721 |
599 |
$1K |
| 84703 |
|
2,602 |
2,158 |
$1K |
| 83655 |
|
117 |
112 |
$1K |
| 84145 |
|
3,627 |
2,699 |
$1K |
| J3490 |
Unclassified drugs |
133,993 |
43,742 |
$1K |
| 87102 |
|
150 |
140 |
$1K |
| 84484 |
|
21,997 |
11,913 |
$1K |
| 70498 |
|
200 |
172 |
$1K |
| 84481 |
|
85 |
79 |
$1K |
| 87506 |
|
13 |
12 |
$1K |
| 94726 |
|
426 |
400 |
$993.62 |
| 83883 |
|
670 |
524 |
$976.61 |
| 84155 |
|
2,018 |
1,634 |
$971.29 |
| 84479 |
|
258 |
223 |
$946.64 |
| 82248 |
|
2,369 |
1,719 |
$836.23 |
| 96523 |
|
39 |
25 |
$828.73 |
| 84270 |
|
51 |
44 |
$788.88 |
| 83013 |
|
12 |
12 |
$771.84 |
| 86160 |
|
61 |
43 |
$745.55 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
349 |
179 |
$722.06 |
| 87040 |
|
3,383 |
2,249 |
$701.25 |
| 84075 |
|
2,019 |
1,716 |
$665.10 |
| 82803 |
|
2,782 |
1,834 |
$631.88 |
| 87493 |
|
39 |
28 |
$590.24 |
| 86666 |
|
117 |
80 |
$544.32 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,972 |
3,471 |
$533.25 |
| 82310 |
|
730 |
622 |
$528.58 |
| 85014 |
|
1,727 |
1,332 |
$475.51 |
| 86592 |
|
153 |
132 |
$459.91 |
| 80164 |
|
93 |
78 |
$437.36 |
| 86152 |
|
18 |
12 |
$424.68 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
170 |
145 |
$410.60 |
| 83521 |
|
341 |
253 |
$370.80 |
| 12001 |
|
473 |
415 |
$369.64 |
| 87634 |
|
473 |
422 |
$356.79 |
| 84134 |
|
31 |
25 |
$348.00 |
| 84156 |
|
213 |
173 |
$334.88 |
| 72040 |
|
99 |
79 |
$322.34 |
| 82951 |
|
27 |
25 |
$319.54 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
20 |
12 |
$312.64 |
| 88307 |
|
147 |
128 |
$311.74 |
| 86735 |
|
39 |
29 |
$286.58 |
| 86765 |
|
39 |
29 |
$283.13 |
| 86376 |
|
24 |
24 |
$275.77 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
677 |
504 |
$270.64 |
| 82948 |
|
16,591 |
7,526 |
$264.46 |
| 82150 |
|
100 |
83 |
$260.10 |
| 12002 |
|
211 |
184 |
$258.50 |
| 84460 |
|
2,699 |
2,317 |
$255.90 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
888 |
723 |
$246.91 |
| 85018 |
|
970 |
776 |
$246.34 |
| 70486 |
|
16 |
14 |
$245.22 |
| 99443 |
|
13 |
13 |
$229.56 |
| 86709 |
|
33 |
24 |
$215.00 |
| 82785 |
|
13 |
13 |
$204.49 |
| 87449 |
|
47 |
41 |
$199.59 |
| 73590 |
|
76 |
56 |
$197.17 |
| 29125 |
|
349 |
308 |
$192.22 |
| 90715 |
|
2,154 |
1,801 |
$189.23 |
| 85041 |
|
652 |
543 |
$176.00 |
| 81015 |
|
86 |
72 |
$171.10 |
| 83605 |
|
8,917 |
6,035 |
$161.96 |
| 84132 |
|
173 |
133 |
$143.56 |
| 87324 |
|
32 |
28 |
$142.60 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,415 |
2,131 |
$141.73 |
| 84144 |
|
27 |
25 |
$139.44 |
| 96376 |
|
6,226 |
3,819 |
$131.70 |
| 84520 |
|
1,107 |
912 |
$129.23 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
430 |
374 |
$117.98 |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,085 |
920 |
$115.37 |
| 82140 |
|
84 |
68 |
$113.85 |
| 82533 |
|
15 |
12 |
$99.00 |
| 82232 |
|
130 |
105 |
$92.70 |
| 83014 |
|
12 |
12 |
$90.12 |
| 88313 |
|
3,009 |
2,654 |
$86.61 |
| 83721 |
|
16 |
14 |
$81.99 |
| 86850 |
|
7,483 |
5,831 |
$79.64 |
| 82330 |
|
82 |
64 |
$69.60 |
| 95251 |
|
359 |
245 |
$62.75 |
| 82977 |
|
33 |
26 |
$61.40 |
| 82553 |
|
306 |
207 |
$52.90 |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,782 |
1,425 |
$41.27 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
121 |
85 |
$39.92 |
| 90686 |
|
21 |
17 |
$38.06 |
| J2060 |
Injection, lorazepam, 2 mg |
4,866 |
3,440 |
$30.93 |
| 86308 |
|
29 |
24 |
$29.64 |
| 94727 |
|
2,281 |
2,031 |
$28.02 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
299 |
216 |
$25.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,308 |
1,162 |
$14.52 |
| A9270 |
Non-covered item or service |
15,913 |
8,501 |
$13.51 |
| 87807 |
|
121 |
114 |
$11.45 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
22,182 |
15,591 |
$10.17 |
| 80051 |
|
23 |
14 |
$9.43 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
8,198 |
5,390 |
$9.41 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,337 |
1,756 |
$7.37 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15,819 |
12,030 |
$5.33 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
17,664 |
14,287 |
$5.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,946 |
2,480 |
$4.80 |
| 84295 |
|
51 |
39 |
$4.59 |
| 82009 |
|
182 |
140 |
$4.31 |
| 82962 |
|
813 |
551 |
$4.29 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
1,025 |
814 |
$4.09 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,505 |
3,409 |
$2.40 |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,026 |
1,577 |
$1.95 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,518 |
4,429 |
$1.94 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
66 |
25 |
$1.87 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,594 |
5,480 |
$1.81 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,694 |
3,448 |
$1.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
103 |
88 |
$0.27 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
62 |
52 |
$0.17 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
45 |
38 |
$0.14 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,991 |
3,008 |
$0.08 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,187 |
1,644 |
$0.00 |
| 76813 |
|
975 |
668 |
$0.00 |
| C1776 |
Joint device (implantable) |
45 |
31 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,396 |
1,097 |
$0.00 |
| 94729 |
|
2,703 |
2,428 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
286 |
212 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,690 |
1,349 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
988 |
685 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,388 |
1,162 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
1,401 |
1,007 |
$0.00 |
| 77002 |
|
88 |
84 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
687 |
540 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
850 |
726 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
586 |
446 |
$0.00 |
| 76942 |
|
312 |
269 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
743 |
645 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
122 |
81 |
$0.00 |
| 93356 |
|
710 |
640 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
12 |
12 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
234 |
77 |
$0.00 |
| 12011 |
|
45 |
38 |
$0.00 |
| 91300 |
|
494 |
446 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
712 |
329 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
337 |
227 |
$0.00 |
| J1453 |
Injection, fosaprepitant, 1 mg |
41 |
24 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
168 |
111 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
412 |
227 |
$0.00 |
| C1874 |
Stent, coated/covered, with delivery system |
16 |
13 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
15 |
13 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,424 |
2,005 |
$0.00 |
| C1769 |
Guide wire |
149 |
90 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
431 |
382 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
8,350 |
5,738 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,777 |
4,342 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
32 |
27 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,733 |
1,478 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
384 |
348 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,827 |
975 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
806 |
565 |
$0.00 |
| 88341 |
|
503 |
419 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
335 |
288 |
$0.00 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
47 |
30 |
$0.00 |
| 96368 |
|
68 |
44 |
$0.00 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
1,109 |
538 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
535 |
455 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
225 |
182 |
$0.00 |
| 91303 |
|
66 |
63 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
298 |
267 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
126 |
40 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
72 |
48 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
193 |
149 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
175 |
139 |
$0.00 |
| 91301 |
|
1,142 |
1,008 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
128 |
108 |
$0.00 |
| 82435 |
|
51 |
38 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
122 |
110 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
202 |
113 |
$0.00 |
| 86880 |
|
77 |
65 |
$0.00 |
| 64494 |
|
16 |
13 |
$0.00 |
| 76870 |
|
18 |
13 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
28 |
26 |
$0.00 |
| 64415 |
|
14 |
12 |
$0.00 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
14 |
12 |
$0.00 |